LMBI March Week 3: FDA New Drug release Video!
Myla Marshall, Legislative, Membership Benefits, and Immigration Chair
Due March 22nd before 5:00pm CDT/6:00pm EST
Possible maximum CIC points:300 points!
The FDA recently approved Esketamine, a nasal spray indicated for resistant depression!
Imagine, a patient enters your pharmacy for their resistant depression. They want to know how Esketamine is any different from any of their other medications they’ve previously tried in the past. Create a short video counseling your “patient” (a peer) on how this drug is predicted to be more effective. Include the route of administration, mechanism of action, duration of onset, and and pertinent side effects they may experience.
Click HERE to see the guidelines in full.
March 17, 2019